SCHEMBL19924686

SCHEMBL19924686

Cc1cc(-c2nccn2C)cn(C)c1=O

nearest known ligand 0.65

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 20/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19924656 0.79 BRD4 (1.00) BRD4
SCHEMBL19924871 0.78 BRD4 (0.67) BRD4
SCHEMBL19927785 0.78 BRD4 (1.00) BRD4
SCHEMBL19924596 0.77 BRD4 (0.86) BRD4
SCHEMBL19924911 0.76 BRD4 (0.84) BRD4
SCHEMBL19924601 0.76 BRD4 (1.00) BRD4
SCHEMBL19936769 0.76 BRD4 (0.82) BRD4
SCHEMBL19924912 0.76 BRD4 (1.00) BRD4
SCHEMBL19937096 0.75 BRD4 (1.00) BRD4
SCHEMBL19924921 0.75 BRD4 (1.00) BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3507283-A1 IMIDAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF AUTOIMMUNE OR INFLAMMATORY DISEASES OR CANCERS Glaxosmithkline Intellectual Property (No. 2) Limited (GB) 2019-07-10 EP disclosed
WO-2018041947-A1 IMIDAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF AUTOIMMUNE OR INFLAMMATORY DISEASES OR CANCERS GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) 2018-03-08 WO disclosed